CompletedNot Applicable

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies

Democratic Republic of the Congo, Madagascar10,602 participantsStarted 2018-04-02

Plain-language summary

This study evaluates the effectiveness of community delivery of sulfadoxine-pyrimetamine (SP) for intermittent preventive treatment of malaria in pregnancy (IPTp) in increasing the coverage of IPTp among pregnant women in selected districts in Democratic Republic of Congo (DRC), Madagascar, Mozambique and Nigeria, compared to comparison districts where SP for IPTp is distributed as usual in facilities through routine antenatal care (ANC).

Who can participate

Age range15 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who had a pregnancy that ended in the 12 months preceding the survey * Being resident in the study area during for at least 4 months before the end of the pregnancy * Willing to participate in the household survey (signing informed consent/assent, in line with country guidelines) Exclusion Criteria: * Anyone considered to be a minor in their country. * Not willing to provide informed consent

What they're measuring

IPTp3 Coverage

Timeframe: 1 year

Trial details

NCT IDNCT03600844

SponsorJhpiego

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-31

View on ClinicalTrials.gov More Malaria in Pregnancy trials